Farmakem specialises in the R&D, production, supply and distribution of active pharmaceutical ingredients.

Founded in December 2015 by four partners sharing expertise in pharmaceutics, industry and commerce, the company now supplies a range of products to customers in the EU and worldwide.

Farmakem holds an EU GMP manufacturing licence for primary and secondary packaging of APIs in powder and liquid form.

Farmakem holds an EU GDP license for the international wholesale, import and export of more than 150 APIs - including CBD, THC, cannabis extracts, cannabis resin and medical cannabis.

Farmakem’s manufacturing facility is located in Hoče, Slovenia and is EU GMP-certified by the Slovenian Agency for Medicinal Products and Medical Devices - JAZMP (a member of the EMA - European Medical Agency).

Farmakem provides full support to customer’s business with high-quality services, guaranteed by Farmakem's expertise.

Farmakem was the first company in Slovenia to be licensed to import medicinal cannabis / delta-9-tetrahydrocannabinol (THC).

In 2017 Farmakem developed the first certified EU cGMP cannabidiol (CBD) API derived from natural source under the brand name Cebexan™, and in 2021 became a GMP pharmaceutical-grade API manufacturer, in collaboration with its British strategic partner.

For the five consecutive years Farmakem has been successfully supplying CBD API to Slovenia’s largest and most prestigious health institution, the University Medical Centre, Ljubljana.

We are aware that the success of the company largely depends on the knowledge within the company. As knowledge is becoming increasingly important, only companies that invest in research and development will be able to maintain their competitiveness and market position.

Farmakem focuses specifically on research and development around the cannabis/hemp plant and its various compounds.

Farmakem is also in the process of obtaining an EU GDP International wholesale licence for the distribution of medicinal products as well as an EU GMP licence for the manufacture and import of medicinal products.

Circular economy and sustainability

In a changing economic and social environment, addressing social and environmental issues is becoming a necessity and an obligation for companies. At Farmakem, we are aware of this. That is why we have adopted an intensive approach to comprehensively consider our impacts, risks and opportunities in the area of sustainable development.

CO-FINANCED PROJECTS: